Shimose, S., Iwamoto, H., Niizeki, T., Shirono, T., Noda, Y., Kamachi, N., . . . Torimura, T. (2020). Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Cancers (Basel).
Citación estilo ChicagoShimose, Shigeo, et al. "Clinical Significance of Adverse Events for Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study." Cancers (Basel) 2020.
Cita MLAShimose, Shigeo, et al. "Clinical Significance of Adverse Events for Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study." Cancers (Basel) 2020.
Precaución: Estas citas no son 100% exactas.